EZH2 and hepatocellular carcinoma: Levels of ubiquitinated EZH2 are increased in DDX11-depleted HCC cells; therefore, it has been proposed that DDX11 might protect EZH2 from proteasome-mediated degradation in these cell lines inhibiting its ubiquitination.